Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
37.01
-0.07 (-0.19%)
At close: Mar 9, 2026, 4:00 PM EDT
36.27
-0.74 (-2.00%)
After-hours: Mar 9, 2026, 6:35 PM EDT
Cogent Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -328.94 | -255.86 | -192.41 | -140.24 | -72.27 | |
| Depreciation & Amortization | 4.58 | 4.35 | 3.59 | 5.88 | 1.99 | |
| Other Amortization | 0.6 | - | - | - | - | |
| Loss (Gain) From Sale of Assets | - | - | 0.01 | - | - | |
| Asset Writedown & Restructuring Costs | - | - | - | -0.4 | - | |
| Loss (Gain) From Sale of Investments | -1.96 | -7.62 | -5.17 | -1.64 | - | |
| Stock-Based Compensation | 46.08 | 39.74 | 30.62 | 18.37 | 11.69 | |
| Other Operating Activities | 7.18 | - | -1.7 | -1.36 | -0.34 | |
| Change in Accounts Payable | -2.51 | 1.36 | 4.81 | 2.36 | 2.75 | |
| Change in Other Net Operating Assets | 10.52 | 10.24 | 6.63 | -1.61 | -2.58 | |
| Operating Cash Flow | -264.44 | -207.79 | -153.62 | -118.64 | -58.76 | |
| Capital Expenditures | -1.55 | -0.57 | -2.8 | -6.86 | -1.72 | |
| Investment in Securities | -397.97 | 38.85 | -95.03 | -117.86 | - | |
| Investing Cash Flow | -399.53 | 38.28 | -97.82 | -124.72 | -1.72 | |
| Long-Term Debt Issued | 272.39 | - | - | - | - | |
| Long-Term Debt Repaid | -54.64 | - | - | - | - | |
| Net Debt Issued (Repaid) | 217.76 | - | - | - | - | |
| Issuance of Common Stock | 752.2 | 214.45 | 174.24 | 174.36 | 39.26 | |
| Repurchase of Common Stock | -48.9 | - | - | - | - | |
| Other Financing Activities | -42.82 | - | -10.7 | -10.8 | -1.29 | |
| Financing Cash Flow | 878.23 | 214.45 | 163.54 | 163.56 | 37.98 | |
| Net Cash Flow | 214.26 | 44.94 | -87.91 | -79.8 | -22.51 | |
| Free Cash Flow | -266 | -208.36 | -156.42 | -125.5 | -60.48 | |
| Free Cash Flow Per Share | -2.06 | -2.00 | -1.96 | -2.13 | -1.56 | |
| Cash Interest Paid | 2.02 | - | - | - | - | |
| Levered Free Cash Flow | -152.49 | -115.91 | -86.68 | -67.08 | -31.78 | |
| Unlevered Free Cash Flow | -151.18 | -115.91 | -86.68 | -67.08 | -31.78 | |
| Change in Working Capital | 8.01 | 11.6 | 11.44 | 0.75 | 0.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.